AI주식인사이트AI Stock Insight
D

국전

307750KOSDAQ의약품 제조업

37.0 / 100

Reference Date: 2026-07-24

Financial Score10.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is below the industry average, Operating Profit is on a declining trend. Slightly down 3.0% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Kukjeon Pharm operates two main business segments: the pharmaceutical division, focusing on the synthesis and distribution of active pharmaceutical ingredients (APIs), and the materials division, developing high-performance specialty materials for advanced industries such as OLEDs, semiconductors, and AI. The company is strengthening its competitiveness through new drug development and global market expansion.

Number of Employees

172people

Average Salary

68.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 11.234.0Point
PBR
1.19Industry Average 0.812.5Point

Higher than industry avg (caution)

ROE
-4.99Industry Average 4.010.0Point

Well below industry avg

Debt Ratio
18.00Industry Average 12.432.0Point

Higher than industry avg (caution)

Trend 2023~20252.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲3.9% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼446.9% (2-year basis)

ROE Trend
1.0 / 4

Avg ROE 0.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (3%, downtrend)

Current 2,105Won52-week high 5,54052-week low 1,972
1-month return2.0Point

1m -3.00% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-07-21
  • Neutral주식등의대량보유상황보고서(일반)2026-07-01